MedPath

A phase II study to evaluate the oral nutrition supplementation for patients undergoing neoadjuvant chemotherapy for esophageal cancer

Phase 2
Recruiting
Conditions
Esophageal cancer
Registration Number
JPRN-UMIN000033895
Lead Sponsor
Tohoku University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
85
Inclusion Criteria

Not provided

Exclusion Criteria

1) BMI <17.0 or >30.0, 2) Excision of other organs excluding stomach or gall bladder, 3) Active double cancer, 4) Pregnancy or breast-feeding, 5) Psychosis or mental symptoms, 6) Systemic administration of steroids, 7) History of myocardial infarction or unstable angina, 8) Poorly controlled hypertension, 9) Poorly controlled diabetes, 10) Respiratory disease requiring sustained oxygen therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath